MMSI - Merit Medical Book Valuation of Business

MMSI (merit.com) - company brandmark

Merit Medical Systems (MMSI) relies on an international system of modern stent and catheter manufacturing plants, ensuring an uninterrupted supply to clinics. This price chart on the GURU.Markets platform confirms that the metric stands at 1.70. The business benefits from the defensive nature of the healthcare sector and the increasing volume of surgeries, while implementing eco-friendly polymer recycling methods and optimizing freight logistics to reduce its carbon footprint.

MMSI Merit Medical Book Capitalization (07/04/2022 - 10/27/2026)

Merit Medical (MMSI) - metric breakdowns and financial figures

- price and consensus price forecast:
Market Chart Merit Medical Corp|MMSI - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Merit Medical Systems Inc|MMSI - Total Company Value
- book capitalization data:
Accounting Value per Share Merit Medical|MMSI - Book Capitalization|Market-to-Book Ratio merit.com|MMSI - Company Total Assets
- debt and liquidity data:
Debt to Equity Ratio Merit Medical Systems|MMSI - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Merit Medical Systems, Inc.|MMSI - Company Aggregate Debts|Debt to Book Value Merit Medical Systems Inc
Fundamental valuation:MMSI - Merit Medical Corp
Mass-produced product of Merit Medical Systems Inc

Institutional investors utilize this metric to determine the intrinsic value of Merit Medical Systems (MMSI), assessing business resilience through the lens of tangible assets. By analyzing this equity volume chart from the balance sheet, which reflects the difference between all assets and liabilities, one can confirm the reliability of the company, whose value is supported by global manufacturing capacities in the US, Ireland, and China.

Competitor analysis for Merit Medical Systems

ISRG - Book Valuation of Business|Danaher Corp. - Book Capitalization|BDX (bd.com) - Book Valuation of Business|Company Book Value STE|Company Net Assets West Pharma|Baxter Corp - Book Capitalization|Total Stockholders' Equity Masimo Inc. (MASI)|STVN - Book Capitalization|Accounting Capitalization teleflex.com TFX|Book Capitalization NVST (Envista)|ICUI - Book Valuation of Business|XRAY (Dentsply) - Book Capitalization|LeMaitre Corp (LMAT) - Company Net Assets|ATRC (AtriCure, Inc.) - Book Capitalization|Book Capitalization STAA|Company Book Value ChromaDex Corporation (NAGE)|Company Book Value ZimVie Inc ZIMV|Company Net Assets AngioDynamics Corp|Accounting Value of Company Cerus Inc CERS|Book Capitalization TKNO (Alpha Teknova, Inc.)|MGRM: Book Valuation of Business|Company Book Value sharpstechnology.com|INFU (InfuSystem Holdings, Inc.) - Accounting Capitalization|UTMD: Company Book Value|Book Valuation of Business KORU Medical Systems Inc. (KRMD)|Company Net Assets Nyxoah S.A.|Total Net Assets MBOT (microbotmedical.com)|Company Book Value Pro-Dex|ZTEK - Accounting Value of Company|Elutia Corp - Company Net Assets|MLSS: Book Capitalization|NXGL (NEXGEL, Inc.) - Company Book Value|Retractable Technologies, Inc. (RVP) - Company Net Assets|Book Capitalization HBIO (Harvard Bioscience, Inc.)|Total Stockholders' Equity FEMY|Company Book Value MeihuaMed MHUA|Accounting Capitalization predictive-oncology.com POAI|Company Net Assets Callan JMB (CJMB)|atrioncorp.com - Total Net Assets|Company Book Value NURO (NeuroMetrix)